Free Trial

Wave Life Sciences (WVE) SEC Filings & 10K Form

Wave Life Sciences logo
$13.67 -1.33 (-8.87%)
(As of 11/15/2024 ET)

Recent Wave Life Sciences SEC Filings

DateFilerForm TypeView
11/15/2024
8:00 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
7:00 PM
Francis Chris (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
Wave Life Sciences (Subject)
Form SC 13G/A
10/30/2024
4:13 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
7:00 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
7:00 PM
Francis Chris (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:13 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
3:19 PM
Francis Chris (Reporting)
Wave Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
7:34 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:15 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
7:00 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:54 PM
GSK plc (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:47 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Wave Life Sciences (Subject)
Form SC 13D/A
10/01/2024
6:35 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
7:00 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
5:09 AM
Wave Life Sciences (Filer)
Form 424B5
09/26/2024
4:18 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
8:40 PM
Moran Kyle (Reporting)
Wave Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/24/2024
4:13 PM
Wave Life Sciences (Filer)
Form 424B3
09/24/2024
4:16 PM
Wave Life Sciences (Filer)
Form 424B5
09/24/2024
6:34 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
5:00 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
TAKANASHI KEN (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Wagner Heidi L (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Verdine Gregory L. (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
CORRIGAN MARK (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
HENRY CHRISTIAN O (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Tan Aik Na (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Rawcliffe Adrian (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:05 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:29 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:55 AM
Wave Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:37 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
4:54 PM
Vargeese Chandra (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
6:36 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:26 PM
Wave Life Sciences (Filer)
Form ARS
05/10/2024
6:30 AM
Wave Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:37 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
7:00 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:55 AM
Wave Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
6:39 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Tesla Trade Is Back In Business (Ad)

If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.

Discover how to trade Tesla, simply follow this link here.
02/13/2024
9:13 AM
BB BIOTECH AG (Filed by)
Wave Life Sciences (Subject)
Form SC 13G/A
02/07/2024
6:00 PM
Vargeese Chandra (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:05 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:10 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:15 PM
Francis Chris (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
7:03 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Wave Life Sciences (Subject)
Form SC 13G/A
02/06/2024
4:07 PM
GSK plc (Filed by)
Wave Life Sciences (Subject)
Form SC 13G/A
01/17/2024
6:06 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Wave Life Sciences (Issuer)
Form 4/A
01/08/2024
7:11 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:07 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
7:36 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
3:33 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
8:26 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
5:06 AM
Wave Life Sciences (Filer)
Form 424B5
12/06/2023
3:13 PM
Wave Life Sciences (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:WVE) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners